Tilray Brands (TLRY) Research & Development (2017 - 2026)
Tilray Brands' (TLRY) quarterly Research & Development came in at $2.0 million in Q2 2026, up 42.41% YoY from $1.4 million in Q2 2025, and up 92.41% on a QoQ basis from $1.0 million in Q1 2026.
Tilray Brands (TLRY) Research & Development (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Research & Development data on file, last reported at $2.0 million in Q2 2026.
- Quarterly Research & Development rose 42.41% year-over-year to $2.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.6 million (down 2.59% YoY) and the FY2026 annual result came in at $5.6 million, down 2.59% from the prior year.
- Research & Development improved to $2.0 million in Q2 2026, from $1.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.0 million in Q2 2026 to a low of $1.0 million in Q1 2026.
- A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 115.64% — and 2025, when it fell 26.34%.
- Tracing TLRY's Research & Development over 5 years: stood at $1.2 million in 2022, then gained by 12.72% to $1.4 million in 2023, then increased by 27.66% to $1.8 million in 2024, then slipped by 26.34% to $1.3 million in 2025, then soared by 51.01% to $2.0 million in 2026.
- The last three Research & Development figures came in at $2.0 million (Q2 2026), $1.0 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Tilray Brands | 516.53 Mn | 281.90 Mn | 90.52 Mn | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 1.95 Mn |
| Feb 28, 2026 | 1.01 Mn |
| Nov 30, 2025 | 1.29 Mn |
| Aug 31, 2025 | 1.31 Mn |
| May 31, 2025 | 1.37 Mn |
| Feb 28, 2025 | 1.10 Mn |
| Nov 30, 2024 | 1.75 Mn |
| Aug 31, 2024 | 1.49 Mn |
| May 31, 2024 | 1.41 Mn |
| Feb 29, 2024 | 1.25 Mn |
| Nov 30, 2023 | 1.37 Mn |
| Aug 31, 2023 | 1.11 Mn |
| May 31, 2023 | 1.05 Mn |
| Feb 28, 2023 | 1.10 Mn |
| Nov 30, 2022 | 1.22 Mn |
| Aug 31, 2022 | 1.16 Mn |
| May 31, 2022 | 1.33 Mn |
| Feb 28, 2022 | 1.10 Mn |
| Nov 30, 2021 | 982,000.00 |
| Aug 31, 2021 | 790,000.00 |